ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93 | -37.6% | 58,889 | +3.9% | 0.00% | – |
| Q2 2023 | $149 | -25.1% | 56,689 | +3.7% | 0.00% | – |
| Q1 2023 | $199 | -6.6% | 54,689 | +0.9% | 0.00% | – |
| Q4 2022 | $213 | -99.9% | 54,189 | -8.0% | 0.00% | – |
| Q3 2022 | $250,000 | -13.8% | 58,889 | -8.3% | 0.00% | – |
| Q2 2022 | $290,000 | -18.5% | 64,189 | +0.8% | 0.00% | – |
| Q1 2022 | $356,000 | -15.8% | 63,689 | -5.9% | 0.00% | -100.0% |
| Q4 2021 | $423,000 | -51.3% | 67,689 | -23.1% | 0.00% | 0.0% |
| Q3 2021 | $869,000 | -50.1% | 87,989 | -55.0% | 0.00% | -50.0% |
| Q2 2021 | $1,742,000 | -45.9% | 195,706 | -32.6% | 0.00% | -50.0% |
| Q1 2021 | $3,221,000 | +36.9% | 290,406 | +4.0% | 0.00% | +33.3% |
| Q4 2020 | $2,353,000 | +32.7% | 279,106 | -6.5% | 0.00% | +50.0% |
| Q3 2020 | $1,773,000 | +28.9% | 298,506 | +9.9% | 0.00% | +100.0% |
| Q2 2020 | $1,375,000 | +209.0% | 271,706 | +186.0% | 0.00% | – |
| Q1 2020 | $445,000 | +38.2% | 94,990 | +147.4% | 0.00% | – |
| Q4 2019 | $322,000 | -49.3% | 38,390 | +61.4% | 0.00% | -100.0% |
| Q3 2019 | $635,000 | +48.4% | 23,790 | +19.6% | 0.00% | – |
| Q2 2019 | $428,000 | +95.4% | 19,890 | +12.4% | 0.00% | – |
| Q1 2019 | $219,000 | – | 17,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 25,000 | $156,000 | 0.11% |
| Golden Green, Inc. | 19,967 | $125,000 | 0.10% |
| ARK Investment Management | 349,308 | $2,183,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 43,000 | $247,000 | 0.01% |
| Belvedere Trading LLC | 17,800 | $98,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $81,000 | 0.00% |
| Renaissance Technologies | 67,689 | $423,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,296 | $21,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,204 | $76,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |